New skin serum passes safety check in small trial
NCT ID NCT07517900
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed study tested whether a topical serum containing Mitopure is safe for healthy adults. Forty participants applied the serum repeatedly over two weeks. Researchers checked for skin irritation and asked about product traits. The trial focused only on safety, not on whether the serum improves skin appearance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mitopure topical serum
- What this could lead to
- If successful, this could support the development of a safe skin serum for cosmetic use.
- What could go wrong
- This is a small, early safety study in healthy people, not designed to test effectiveness. Results may not apply to people with skin conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
PCR Corp
Manchester, M13 0AF, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new antibody tame the Body's allergic alarm system?
- Fingerprint sweat could replace oral swabs for drug testing
- Wearable tech puts hormone health to the test
- Can a better hazmat suit keep first responders safer and more effective?
- Home video tracking may expose the gap between clinic walking and real-world walking after stroke
- Avocado at breakfast: a secret weapon for blood sugar and fullness?